The clinical implications of cytochrome P450 interactions with opioids and strategies for pain management

17Citations
Citations of this article
39Readers
Mendeley users who have this article in their library.

Abstract

Pharmacokinetic differences among opioids influence a patient's response to opioid treatment. An important element affecting a drug's pharmacokinetics, its metabolism, may be altered under various circumstances, thereby enhancing or mitigating a patient's response to opioids. The genetic background of the metabolic enzymes involved in opioid metabolism, comorbid medical conditions, older age, and the presence of other drugs that influence metabolism are such factors that can cause the response to opioid therapy to vary greatly from the expected response to a standard dose. As a result of the variability in individual responses to opioids, clinical management of pain with opioids must be empirical. © 2012 Published by Elsevier Inc. on behalf of U.S. Cancer Pain Relief Committee.

Cite

CITATION STYLE

APA

Brennan, M. J. (2012). The clinical implications of cytochrome P450 interactions with opioids and strategies for pain management. Journal of Pain and Symptom Management, 44(6 SUPPL.). https://doi.org/10.1016/j.jpainsymman.2012.08.012

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free